1. Home
  2. VGAS vs CTSO Comparison

VGAS vs CTSO Comparison

Compare VGAS & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verde Clean Fuels Inc.

VGAS

Verde Clean Fuels Inc.

N/A

Current Price

$1.07

Market Cap

28.7M

Sector

Industrials

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$3.59

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VGAS
CTSO
Founded
2007
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.7M
23.9M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
VGAS
CTSO
Price
$1.07
$3.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 16.0K
8.9K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.79
EPS
★ N/A
N/A
Revenue
N/A
★ $22,503,908.00
Revenue This Year
N/A
$4.91
Revenue Next Year
N/A
$13.58
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 48.53
52 Week Low
$0.92
$0.30
52 Week High
$3.36
$7.44

Technical Indicators

Market Signals
Indicator
VGAS
CTSO
Relative Strength Index (RSI) 38.56 46.64
Support Level $0.95 $2.89
Resistance Level $1.20 $4.22
Average True Range (ATR) 0.09 0.46
MACD -0.01 -0.22
Stochastic Oscillator 7.69 9.19

Price Performance

Historical Comparison
VGAS
CTSO

About VGAS Verde Clean Fuels Inc.

Verde Clean Fuels Inc is a renewable energy company specializing in the conversion of synthesis gas, or syngas, derived from diverse feedstocks, such as biomass, MSW, and mixed plastics, as well as natural gas (including synthetic natural gas) and other feedstocks, into liquid hydrocarbons that can be used as gasoline through a proprietary liquid fuels technology, the STG process.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: